Lord, Abbett & Co’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-827,577
Closed -$38.9M 576
2023
Q2
$38.9M Buy
827,577
+637,244
+335% +$30M 0.13% 222
2023
Q1
$7.99M Buy
+190,333
New +$7.99M 0.03% 429
2019
Q4
Sell
-221,994
Closed -$31.1M 733
2019
Q3
$31.1M Sell
221,994
-256,617
-54% -$36M 0.11% 317
2019
Q2
$87.6M Sell
478,611
-142,057
-23% -$26M 0.28% 95
2019
Q1
$98.7M Buy
620,668
+492,910
+386% +$78.4M 0.33% 71
2018
Q4
$12.2M Sell
127,758
-172,807
-57% -$16.6M 0.04% 498
2018
Q3
$42.5M Sell
300,565
-240,313
-44% -$33.9M 0.12% 289
2018
Q2
$84.7M Buy
540,878
+73,024
+16% +$11.4M 0.25% 114
2018
Q1
$75.4M Sell
467,854
-203,681
-30% -$32.8M 0.22% 122
2017
Q4
$111M Buy
671,535
+395,870
+144% +$65.2M 0.31% 68
2017
Q3
$17.2M Sell
275,665
-86,023
-24% -$5.36M 0.05% 513
2017
Q2
$28.8M Sell
361,688
-332,818
-48% -$26.5M 0.09% 354
2017
Q1
$49.4M Buy
694,506
+121,452
+21% +$8.63M 0.15% 214
2016
Q4
$29.3M Sell
573,054
-105,994
-16% -$5.41M 0.09% 322
2016
Q3
$31.3M Sell
679,048
-43,752
-6% -$2.01M 0.1% 335
2016
Q2
$21.8M Buy
722,800
+191,396
+36% +$5.77M 0.07% 395
2016
Q1
$17M Sell
531,404
-563,879
-51% -$18.1M 0.05% 453
2015
Q4
$63.9M Buy
1,095,283
+834,915
+321% +$48.7M 0.19% 145
2015
Q3
$11M Sell
260,368
-826,741
-76% -$35M 0.03% 563
2015
Q2
$79.4M Buy
1,087,109
+907,212
+504% +$66.2M 0.21% 125
2015
Q1
$9.04M Buy
179,897
+71,671
+66% +$3.6M 0.02% 645
2014
Q4
$3.96M Buy
+108,226
New +$3.96M 0.01% 774